Company intelligence / Profile preview

Altamont Pharmaceutical Holdings

San Jose, California, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Altamont Pharmaceutical Holdings is an investment and incubation firm specializing in small to mid-cap, publicly traded biotech companies and licensing innovative technologies from academic institutions. It provides capital and strategic support for clinical development and commercialization, with a focus on a broad array of therapeutic areas. Cessation Therapeutics is a notable portfolio company.

Industry: Investors

Beyond the preview

Go deeper on Altamont Pharmaceutical Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Altamont Pharmaceutical Holdings.

Explore the full profile